A candidate gene approach identifies the TRAF1/C5 region as a risk factor for rheumatoid arthritis

PLoS Medicine

Volumn 4, Issue 9, 2007, Pages 1515-1524

  Kurreeman, Fina A S ^a   Padyukov, Leonid ^b   Marques, Rute B ^a   Schrodi, Steven J ^c   Seddighzadeh, Maria ^b   Stoeken Rijsbergen, Gerrie ^a   Van Der Helm Van Mil, Annette H M ^a   Allaart, Cornelia F ^a   Verduyn, Willem ^a   Houwing Duistermaat, Jeanine ^a   Alfredsson, Lars ^d   Begovich, Ann B ^c   Klareskog, Lars ^b   Huizinga, Tom W J ^a   Toes, Rene E M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c CELERA   (United States)

^d KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C5; HLA ANTIGEN; SPACER DNA; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 1;

ADULT; ARTICLE; AUTOIMMUNE DISEASE; CASE CONTROL STUDY; CHROMOSOME 9Q; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; GENE IDENTIFICATION; GENE LOCUS; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; OUTCOME ASSESSMENT; PROTEIN FUNCTION; PROTEIN STRUCTURE; RADIODIAGNOSIS; RHEUMATOID ARTHRITIS; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL ANALYSIS; SWEDEN; UNITED STATES;

EID: 34848842161     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.0040278     Document Type: Article

References (33)

1. Firestein GS (2003) Evolving concepts of rheumatoid arthritis. Nature 423: 356-361.
2. Seldin MF, Amos CI, Ward R, Gregersen PK (1999) The genetics revolution and the assault on rheumatoid arthritis. Arthritis Rheum 42: 1071-1079.
3. MacGregor AJ, Snieder H, Rigby AS, Koskenvuo M, Kaprio J, et al. (2000) Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins. Arthritis Rheum 43: 30-37.
4. Deighton CM, Walker DJ, Griffiths ID, Roberts DF (1989) The contribution of HLA to rheumatoid arthritis. Clin Genet 36: 178-182.
5. Begovich AB, Carlton VE, Honigberg LA, Schrodi SJ, Chokkalingam AP, et al. (2004) A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am J Hum Genet 75: 330-337.
6. Maini RN (2004) Current and new antitumor necrosis factor agents in perspective. Arthritis Res Ther 6: S1-S2.
7. Wang Y, Kristan J, Hao L, Lenkoski CS, Shen Y, et al. (2000) A role for complement in antibody-mediated inflammation: C5-deficient DBA/1 mice are resistant to collagen-induced arthritis. J Immunol 164: 4340-4347.
8. Wang Y, Rollins SA, Madri JA, Matis LA (1995) Anti-C5 monoclonal antibody therapy prevents collagen-induced arthritis and ameliorates established disease. Proc Natl Acad Sci U S A 92: 8955-8959
9. Hogasen K, Mollnes TE, Harboe M, Gotze O, Hammer HB, et al. (1995) Terminal complement pathway activation and low lysis inhibitors in rheumatoid arthritis synovial fluid. J Rheumatol 22: 24-28.
10. Grant EP, Picarella D, Burwell T, Delaney T, Croci A, et al. (2002) Essential role for the C5a receptor in regulating the effector phase of synovial infiltration and joint destruction in experimental arthritis. J Exp Med 196: 1461-1471.
11. Ji H, Gauguier D, Ohmura K, Gonzalez A, Duchatelle V, et al. (2001) Genetic influences on the end-stage effector phase of arthritis. J Exp Med 194: 321-330.
12. Eyre S, Barton A, Shephard N, Hinks A, Brintnell W, et al. (2004) Investigation of susceptibility loci identified in the UK rheumatoid arthritis whole-genome scan in a further series of 217 UK affected sibling pairs. Arthritis Rheum 50: 729-735.
13. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, et al. (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31: 315-324.
14. Brinkman BM, Huizinga TW, Kurban SS, van der Velde EA, Schreuder GM, et al. (1997) Tumour necrosis factor alpha gene polymorphisms in rheumatoid arthritis: association with susceptibility to, or severity of, disease? Br J Rheumatol 36: 516-521.
15. Goekoop-Ruiterman YP, Vries-Bouwstra JK, Allaart CF, van Zeben D, Kerstens PJ, et al. (2005) Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): A randomized, controlled trial. Arthritis Rheum 52: 3381-3390.
16. van Aken J, van Bilsen JH, Allaart CF, Huizinga TW, Breedveld FC (2003) The Leiden Early Arthritis Clinic. Clin Exp Rheumatol 21: S100-S105.
17. Padyukov L, Silva C, Stolt P, Alfredsson L, Klareskog L (2004) A gene-environment interaction between smoking and shared epitope genes in HLA-DR provides a high risk of seropositive rheumatoid arthritis. Arthritis Rheum 50: 3085-3092.
18. Barrett JC, Fry B, Maller J, Daly MJ (2005) Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics 21: 263-265.
19. Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, et al. (2002) The structure of haplotype blocks in the human genome. Science 296: 2225-2229.
20. Stram DO, Haiman CA, Hirschhorn JN, Altshuler D, Kolonel LN, et al. (2003) Choosing haplotype-tagging SNPS based on unphased genotype data using a preliminary sample of unrelated subjects with an example from the Multiethnic Cohort Study. Hum Hered 55: 27-36.
21. Schaid DJ, Rowland CM, Tines DE, Jacobson RM, Poland GA (2002) Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet 70: 425-434.
22. Cucherat M, Boissel JP, Leizorovicz A, Haugh MC (1997) EasyMA: A program for the meta-analysis of clinical trials. Comput Methods Programs Biomed 53: 187-190.
23. Lohmueller KE, Pearce CL, Pike M, Lander ES, Hirschhorn JN (2003) Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat Genet 33: 177-182.
24. Breslow NE, Day NE (1980) Statistical methods in cancer research. Volume I - The analysis of case-control studies. IARC Sci Publ 5-338.
25. van der Heijde DM (1996) Plain X-rays in rheumatoid arthritis: Overview of scoring methods, their reliability and applicability. Baillieres Clin Rheumatol 10: 435-453.
26. Marinescu VD, Kohane IS, Riva A (2005) MAPPER: A search engine for the computational identification of putative transcription factor binding sites in multiple genomes. BMC Bioinformatics 6: 79.
27. van Gaalen F, Ioan-Facsinay A, Huizinga TW, Toes RE (2005) The devil in the details: The emerging role of anticitrulline autoimmunity in rheumatoid arthritis. J Immunol 175: 5575-5580.
28. The Wellcome Trust Case Control Consortium (2007) Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447: 661-678.
29. Wajant H, Henkler F, Scheurich P (2001) The TNF-receptor-associated factor family: Scaffold molecules for cytokine receptors, kinases and their regulators. Cell Signal 13: 389-400.
30. Sabbagh L, Srokowski CC, Pulle G, Snell LM, Sedgmen BJ, et al. (2006) A critical role for TNF receptor-associated factor 1 and Bim down-regulation in CD8 memory T cell survival. Proc Natl Acad Sci U S A 103: 18703-18708.
31. Zapata JM, Krajewska M, Krajewski S, Kitada S, Welsh K, et al. (2000) TNFR-associated factor family protein expression in normal tissues and lymphoid malignancies. J Immunol 165: 5084-5096.
32. Cardon LR, Palmer LJ (2003) Population stratification and spurious allelic association. Lancet 361: 598-604.
33. Kallberg H, Padyukov L, Plenge RM, Ronnelid J, Gregersen PK, et al. (2007) Gene-gene and gene-environment interactions involving HLA-DRB1, PTPN22, and smoking in two subsets of rheumatoid arthritis. Am J Hum Genet 80: 867-875.